WHO Board To Address Reform Progress, R&D Financing, Lobbyists/ Foundations

Next week, the World Health Organization Executive Board will hold its biannual meeting. On the agenda are key subjects such as the WHO reform process, sharing of influenza viruses for R&D, and a controversial framework for the WHO’s engagement with actors such as non-governmental organisations, private entities, and foundations. Also on the agenda is the effort to address the growing microbial resistance to antibiotics, and finding a way to finance research and development for diseases affecting primarily developing countries.








